CALCIUM GLUCONATE

Post-LOE

calcium gluconate

B. Braun

ANDAINTRAVENOUSSOLUTION

Approved

Aug 2023

Lifecycle

Post-LOE

Competitive Pressure

30/100

Clinical Trials

Data completeness

3/8 — Basic

CALCIUM GLUCONATE (calcium gluconate) by B. Braun is level. First approved in 2023.

Drug data last refreshed 20h ago

Mechanism of Action

level. Calcium gluconate dissociates into ionized calcium in plasma. Ionized calcium and gluconate are normal constituents of body fluids.

Indications

Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.

Clinical Trials (2)

NCT01099449Phase 3Completed

Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy

Started Jun 2010

362 enrolled

Chemotherapeutic Agent ToxicityColorectal CancerNeuropathy+1 more

NCT00316914Phase 3Completed

Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity Caused By Oxaliplatin in Patients Receiving Combination Chemotherapy for Stage II, Stage III, or Stage IV Colorectal Cancer That Has Been Completely Removed By Surgery

Started Jan 2006

104 enrolled

Colorectal CancerNeurotoxicity

Company

Worked on CALCIUM GLUCONATE at B. Braun? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.